EphA4 protein activation inhibitor (University of Queensland)

N/A

Report date: 2025/03/20 15:27:46

Base Information

Drug NameEphA4 protein activation inhibitor (University of Queensland)
Drug Alias NameEphA4-Fc fusion protein (University of Queensland)ephrin type-A receptor 4 protein activation inhibitor (University of Queensland)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionErythropoietin-producing hepatocellular receptor A4 blockers
TargetsErythropoietin-producing hepatocellular receptor A4
Therapy Area/IndicationsMotor Neuron DiseaseSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesUniquest Pty LtdThe University Of Queensland
Inactive CompaniesN/A
Active IndicationsMotor Neuron DiseaseSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A